Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux

Contact Dermatitis

Volumn 51, Issue 3, 2004, Pages 149-151

  Hohenstein, E ^a   Tsakiris, D ^a   Bircher, A J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Anticoagulation; Cutaneous adverse drug reaction; Delayed type hypersensitivity; Fondaparinux; Heparin; Pentasaccharide; Therapeutic alternatives

Indexed keywords

DALTEPARIN; DANAPAROID; FONDAPARINUX; HEPARINOID; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; CASE REPORT; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; INTRACUTANEOUS TEST; PATCH TEST; PROVOCATION TEST; RASH;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DALTEPARIN; DERMATITIS, ALLERGIC CONTACT; DRUG ERUPTIONS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; POLYSACCHARIDES; RISK FACTORS; TIME FACTORS;

EID: 7044284908     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-1873.2004.0426c.x     Document Type: Article

References (10)

1. Cheng J W. Fondaparinux: a new antithrombotic agent. Clin Ther 2002: 24:1757-1769.
2. Koch P. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux. Contact Dermatitis 2004: 49: 276-280.
3. Ludwig R J, Beier Ch, Lindhoff-Last E, Kaufmann R, Boehncke W H. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. Contact Dermatitis 2003: 49: 158.
4. Maetzke J, Hinrichs R, Staib G, Scharffetter-Kochanek K. Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy. Allergy 2004: 59: 237-238.
5. Sacher C, Hunzelmann N. Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitization. Allergy 2003: 58: 1318-1319.
6. Parody R, Oliver A, Souto J C, Fontcuberta J. Fondaparinux (Arixtra®), as an alternative anitthrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 2003: 880: ERC32.
7. Juschka U, Jappe U. Fondaparinux: Die Alternative bei Typ-IV-Allergie gegenüber Heparinen und Heparinoiden? Allergo J 2004: 13: 54.
8. Bircher A J, Flückiger R, Buechner S A. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction. Br J Dermatol 1990: 123:507-514.
9. Kroon C, DeBoer A, Kroon J, Schoenmaker H, van den Meer F, Cohen A. Influences of skin fold thickness on heparin absorption. Lancet 1991: 337: 945-946.
10. Nasstrom B, Stegmayr B G, Olivecrona G, Olivecrona T. Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme. J Lab Clin Med 2003: 142: 90-99.